RESUMEN
BACKGROUND AND AIMS: The lack of tissue traction and instrument dexterity to allow for adequate visualization and effective dissection were the main issues in performing endoscopic submucosal dissection (ESD). Robot-assisted systems may provide advantages. In this study we developed a novel transendoscopic telerobotic system and evaluated its performance in ESD. METHODS: A miniature dual-arm robotic endoscopic assistant for minimally invasive surgery (DREAMS) was developed. The DREAMS system contained the current smallest robotic ESD instruments and was compatible with the commercially available dual-channel endoscope. After the system was established, a prospective randomized controlled study was conducted to validate the performance of the DREAMS-assisted ESD in terms of efficacy, safety, and workload by comparing it with the conventional technique. RESULTS: Two robotic instruments can achieve safe collaboration and provide sufficient visualization and efficient dissection during ESD. Forty ESDs in the stomach and esophagus of 8 pigs were completed by DREAMS-assisted ESD or conventional ESD. Submucosal dissection time was comparable between the 2 techniques, but DREAMS-assisted ESD demonstrated a significantly lower muscular injury rate (15% vs 50%, P = .018) and workload scores (22.30 vs 32.45, P < .001). In the subgroup analysis of esophageal ESD, DREAMS-assisted ESD showed significantly improved submucosal dissection time (6.45 vs 16.37 minutes, P = .002), muscular injury rate (25% vs 87.5%, P = .041), and workload (21.13 vs 40.63, P = .001). CONCLUSIONS: We developed a novel transendoscopic telerobotic system, named DREAMS. The safety profile and technical feasibility of ESD were significantly improved with the assistance of the DREAMS system, especially in the narrower esophageal lumen.
Asunto(s)
Resección Endoscópica de la Mucosa , Procedimientos Quirúrgicos Robotizados , Animales , Resección Endoscópica de la Mucosa/instrumentación , Resección Endoscópica de la Mucosa/métodos , Esófago/cirugía , Estudios Prospectivos , Estómago/cirugía , Porcinos , Resultado del Tratamiento , Procedimientos Quirúrgicos Robotizados/instrumentación , Procedimientos Quirúrgicos Robotizados/métodosRESUMEN
OBJECTIVE: Surgical robot has advantages in high accuracy and stability. But during the robot-assisted bone surgery, the lack of force information from surgical area and incapability of intervention from surgeons become the obstacle. The aim of the study is to introduce a collaborative control method based on the force feedback and optical navigation, which may optimally combine the excellent performance of surgical robot with clinical experiences of surgeons. MATERIALS AND METHODS: The CMF ROBOT system was integrated with the force feedback system to ensure the collaborative control. Force-velocity control algorithm based on force feedback was designed for this control method. In the preliminary experimental test, under the collaborative control mode based on force feedback and optical navigation, the craniomaxillofacial surgical robot entered the osteotomy line area according to the preoperative surgical plan, namely, right maxillary Le Fort I osteotomy, left maxillary Le Fort I osteotomy, and genioplasty. RESULTS: The force sensor was able to collect and record the resistance data of the cutting process of the robot-assisted craniomaxillofacial osteotomy assisted in real time. The statistical results showed that the repeatability of collaborative control mode was acceptable in bilateral maxillary Le Fort I osteotomies (right, P =0.124>0.05 and left, P =0.183>0.05) and unfavorable in genioplasty ( P =0.048<0.05). CONCLUSION: The feasibility of robot-assisted craniomaxillofacial osteotomy under the collaborative control method based on the force feedback and optical navigation was proved in some extent. The outcome of this research may improve the flexibility and safety of surgical robot to meet the demand of craniomaxillofacial osteotomy.
Asunto(s)
Osteotomía Le Fort , Robótica , Retroalimentación , Mentoplastia , Humanos , Maxilar/cirugía , Osteotomía Le Fort/métodosRESUMEN
OBJECTIVE: Orthognathic surgery is an effective method to correct the dentomaxillofacial deformities. The aim of the study is to introduce the robot-assisted orthognathic surgery and demonstrate the accuracy and feasibility of robot-assisted osteotomy in transferring the preoperative virtual surgical planning (VSP) into the intraoperative phase. METHODS: The CMF robot system, a craniomaxillofacial surgical robot system was developed, consisted of a robotic arm with 6 degrees of freedom, a self-developed end-effector, and an optical localizer. The individualized end-effector was installed with reciprocating saw so that it could perform osteotomy. The study included control and experimental groups. In control group, under the guidance of navigation system, surgeon performed the osteotomies on 3 skull models. In experimental group, according to the preoperative VSP, the robot completed the osteotomies on 3 skull models automatically with assistance of navigation. Statistical analysis was carried out to evaluate the accuracy and feasibility of robot-assisted orthognathic surgery and compare the errors between robot-assisted automatic osteotomy and navigation-assisted manual osteotomy. RESULTS: All the osteotomies were successfully completed. The overall osteotomy error was 1.07â±â0.19 mm in the control group, and 1.12â±â0.20 mm in the experimental group. No significant difference in osteotomy errors was found in the robot-assisted osteotomy groups (Pâ=â0.353). There was consistence of errors between robot-assisted automatic osteotomy and navigation-assisted manual osteotomy. CONCLUSION: In robot-assisted orthognathic surgery, the robot can complete an osteotomy according to the preoperative VSP and transfer a preoperative VSP into the actual surgical operation with good accuracy and feasibility.
Asunto(s)
Procedimientos Quirúrgicos Ortognáticos , Procedimientos Quirúrgicos Robotizados , Humanos , Errores Médicos , Procedimientos Quirúrgicos Ortognáticos/métodos , Cráneo , Programas InformáticosRESUMEN
PURPOSE: Although the relationship between oral contraceptive (OC) use and colorectal cancer (CRC) risk has been studied extensively, the results of epidemiological studies are controversial. Therefore, we carried out a meta-analysis of epidemiological studies to summarize the available evidence and to quantify the potential dose-response relation. METHODS: We searched PubMed database for studies of OC use and CRC risk that were published until the end of March 2014. Random- and fixed-effects models were applied to estimate summary relative risks (RRs) and 95 % confidence intervals (CIs). RESULTS: Twelve cohorts and seventeen case-control studies with a total of 15,790 CRC cases were included in the final analysis. The summary RR for the ever versus never category of OC use was 0.82 (95 % CI 0.76-0.88). Similar result was observed when we compared the longest duration of OC use with the shortest duration (RR = 0.86, 95 % CI 0.76-0.96). Furthermore, the results of stratified analysis were comparable to those of overall meta-analysis. In dose-response analysis, significant inverse associations emerged in nonlinear models for the duration of OC use and CRC (P nonlinearity = 0.001). The greatest risk reduction was observed when the duration of OC use was approximately 42 months. There was moderate heterogeneity in the analysis, and no evidence of small-study bias was observed. CONCLUSIONS: Based on the findings of this meta-analysis, ever use of OC is associated with lower risk of CRC. Additionally, there is a statistically significant nonlinear inverse association between the duration of OC use and CRC risk.
Asunto(s)
Neoplasias Colorrectales/epidemiología , Anticonceptivos Orales/administración & dosificación , Estudios de Casos y Controles , Estudios de Cohortes , Neoplasias Colorrectales/etiología , Neoplasias Colorrectales/prevención & control , Femenino , Humanos , Factores de Riesgo , Factores de TiempoRESUMEN
PURPOSE: The authors aimed to develop 1 novel navigation-guided robotic system for craniofacial surgery to improve accuracy during operation. MATERIALS AND METHODS: A new 7-DOF (7-degree-of-freedom) robotic arm was designed and manufactured. Based on our self-developed navigation system TBNAVIS-CMFS, the key technique of integration was studied. A phantom skull model was manufactured based on computed tomography image data and used for the preexperimental study. Firstly, virtual planning was achieved through the TBNAVIS-CMFS, where the Le Fort I procedure was executed through simulation. Then, the actual Le Fort 1 osteotomy was expected to perform with the use of the robotic arm following the instructions from the navigation system. RESULTS: The theoretical prototype of navigation-guided robotic system for craniofacial surgery was established successfully, which performed the planned Le Fort I procedure with the whole process visible on the screen. CONCLUSIONS: The technical method of navigation-guided robotics system, allowing the operator to practice the virtual planning procedure through navigation system as well as perform the actual operation thru the robotic arm, could be regarded as a valuable option for benefiting craniofacial surgeons.
Asunto(s)
Huesos Faciales/cirugía , Osteotomía/métodos , Procedimientos Quirúrgicos Robotizados/métodos , Cráneo/cirugía , Simulación por Computador , Humanos , Modelos Anatómicos , Tempo Operativo , Osteotomía Le Fort/métodos , Planificación de Atención al Paciente , Tomografía Computarizada por Rayos X/métodos , Interfaz Usuario-ComputadorRESUMEN
Surgical robotic technology is characterized by its high accuracy, good stability, and repeatability. The accuracy of mandibular osteotomy is important in tumor resection, function reconstruction, and abnormality correction. This study is designed to compare the operative accuracy between robot-assisted osteotomy and surgical guide technique in the skull model trials which simulated the genioplasty. In an experimental group, robot-assisted chin osteotomy was automatically performed in 12 models of 12 patients according to the preoperative virtual surgical planning (VSP). In a control group, with the assistance of a surgical guide, a surgeon performed the chin osteotomy in another 12 models of the same patients. All the mandibular osteotomies were successfully completed, and then the distance error and direction error of the osteotomy plane were measured and analyzed. The overall distance errors of the osteotomy plane were 1.57 ± 0.26 mm in the experimental group and 1.55 ± 0.23 mm in the control group, and the direction errors were 7.99 ± 1.10° in the experimental group and 8.61 ± 1.05° in the control group. The Bland-Altman analysis results revealed that the distance error of 91.7% (11/12) and the direction error of 100% (12/12) of the osteotomy plane were within the 95% limits of agreement, suggesting the consistency of differences in the osteotomy planes between the two groups. Robot-assisted chin osteotomy is a feasible auxiliary technology and achieves the accuracy level of surgical guide-assisted manual operation.
RESUMEN
Using the CARS (coherent anti-Stokes Raman spectroscopy) detection technique, the authors investigated the electronic-to-rovibrational levels energy transfer between electronically excited Rb2 and H2. In this CARS experiment, the S-branch (delta upsilon = 1, delta J = 2) transition of H2 was excited by two laser pulses, the pump and the Stokes, respectively, centered at 532 and 690 nm. The internal state distribution of collisionally populated H2 was probed. The scanned CARS spectra reveal that during energy transfer processes H2 molecules were produced only at the upsilon = 1, J = 1,2 and upsilon = 2, J = 0,1,2 rovibrational levels. From scanned CARS spectral peaks the population ratios were obtained. The n1/n5, n2/n5, n3/n5 and n4/n5 are 3.57 +/- 0.71, 2.65 +/- 0.53, 3.00 +/- 0.60 and 0.93 +/- 0.17, respectively, where n1, n2, n3, n4 and n5 represent the number densities of H2 at the rovibrational levels (2,0), (2,1), (2,2), (1,1) and (1,2), respectively. The population ratios indicate that the H2 molecules produced by the energy transfer process are 83% populated at the upsilon = 2 vibrational level and 17% at upsilon = 1. The relative fractions (
RESUMEN
The authors have investigated collision vibrational energy transfer rate constants in NaK[1 3Pi(v)] and He system. Pump laser excitation of the spin-forbidden band was used to produce very highly vibrationally excited metastable state NaK[1 3Pi (v = 22, 21, 20)]. The probe laser was used to excite the 1 3Pi (v = 22, 21, 20) to 5 3Pi(v'). Laser induced fluorescence (LIF) from 5 3Pi --> 1 3Sigma+ transition was used to follow the collision dynamics. The semilog plots of time-resolved LIF was obtained. The slopes yielded the effective lifetimes. From such data several Stern-Volmer plots could be constructed and the relaxation rate constants could be extracted for the sum of all processes that give rise to the decay of the prepared vibrational state. The rate constants (in units of 10(-11) cm3 x s(-1)) for v being 22, 21 and 20 are 1.4 +/- 0.1, 1.2 +/- 0.1 and 1.0 +/- 0.1, respectively. The vibrational relaxation rate is increasing with vibrational quantum number. In order to determine the importance of multiquantum relaxation, it is necessary to measure the relative population of both the prepared state and collisionally populated states. By the kinetic equations governing up to Delta(v) = 2 transitions, the time dependence of populations of the vibrational states were obtained. With the help of the integrating the population equations over all time, the importance of the two-quantum relaxation could be studied experimentally. By varying the delay between the pump and the probe laser, the He pressure dependent vibrational state specific decay could be measured. The time evolutions and relative intensities of the three states v = 22, 21 and 20 by preparing v = 22 were obtained. Using experimental data the rate constants (in units of 10(-11) cm3 x s(-1)) for v = 22 --> 21 and v = 22 --> 20 are 0.67 +/- 0.15 and 0.49 +/- 0.12, respectively. The single quantum relaxation accounts for only about 48% of the total relaxation out of v = 22. Multi-quantum relaxation (Delta(v) > 1) was found to be important at high vibrational states.
RESUMEN
OBJECTIVE: To investigate the role of hypoxia inducible factor (HIF)-prolyl hydroxylase 1 (HPH1) and factor inhibiting HIF-1 (FIH-1) in placentas in the pathogenesis and development of severe pre-eclampsia. METHODS: RT-PCR and western blot analyses were used to detect the HPH1 and FIH-1 expression levels in placentas of 34 patients with severe pre-eclampsia and 24 cases of term pregnancy (normal pregnancy group) and their correlations with symptoms were analyzed. RESULTS: (1) The HPH1 mRNA and protein expression levels in placentas of severe pre-eclampsia group were 0.40 +/- 0.04 and 59.5 +/- 3.4 separately, significantly lower than those of normal pregnancy group, 0.84 +/- 0.12 and 71.6 +/- 1.7 (P < 0.01). The FIH-1 mRNA and protein expression levels in placentas of severe pre-eclampsia group were 0.31 +/- 0.05 and 45.6 +/- 2.4 separately, significantly lower than those of normal pregnancy group, 0.43 +/- 0.04 and 54.9 +/- 2.1 (P < 0.01). (2) The mRNA and protein expression levels of HPH1 and FIH-1 in severe pre-eclampsia group were all negatively correlated with mean arterial pressure (MAP) [the Spearman correlation coefficient was -0.854 (P < 0.01)], urinary protein per 24 hours [the Spearman correlation coefficient was -0.936 (P < 0.01)] and the occurrence of fundus oculi artery spasm [the Spearman correlation coefficient was -0.854 (P < 0.01)]. (3) The expression of HPH1 mRNA in placentas of all the 58 cases was 0.58 +/- 0.27, higher than the expression of FIH-1 mRNA, which was 0.39 +/- 0.10. There was a positive correlation between them. The pearson correlation coefficient was 0.686 (P < 0.01). The expression of HPH1 protein in placentas of all the 58 cases was 64.5 +/- 6.7, higher than the expression of FIH-1, which was 49.4 +/- 5.2. There was a positive correlation between them. The Pearson correlation coefficient was 0.947 (P < 0.01). CONCLUSION: The expression imbalance of HPH1 and FIH-1 in placenta may play an important role in the pathogenesis and development of severe pre-eclampsia through inhibiting HIF-1alpha.
Asunto(s)
Dioxigenasas/metabolismo , Oxigenasas de Función Mixta/metabolismo , Proteínas Nucleares/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Proteínas Represoras/metabolismo , Adulto , Presión Sanguínea , Western Blotting , Dioxigenasas/genética , Femenino , Humanos , Prolina Dioxigenasas del Factor Inducible por Hipoxia , Oxigenasas de Función Mixta/genética , Proteínas Nucleares/genética , Preeclampsia/etiología , Preeclampsia/patología , Embarazo , Procolágeno-Prolina Dioxigenasa , ARN Mensajero/genética , ARN Mensajero/metabolismo , Proteínas Represoras/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Índice de Severidad de la EnfermedadRESUMEN
OBJECTIVE: To evaluate different expressions of high mobility group box 1 (HMGB1) and receptor for advanced glycation end products (RAGE) in placentas and their relationship with pre-eclampsia. METHODS: Fifteen early-onset pre-eclamptic women (early-onset pre-eclampsia group), 22 late-onset pre-eclamptic women (late-onset pre-eclampsia group) and 12 normotensive women (control group) in the third trimester were recruited at the Shengjing Hospital of China Medical University from March 2006 to March 2007. The localization and levels of HMGB1 and RAGE in placentas of the three groups were detected by the strept avidin biotin-peroxidase method. RESULTS: (1) Immunoreactivities to HMGB1: positive immunostaining for HMGB1 was observed in trophoblast, macrophages, decidual cells, vascular muscle cells, endothelial cells and placental mesenchymal cells in the placentas from the pre-eclamptic women, while a low level of immunoreactivities was observed in the placentas from healthy pregnancies; the staining was observed within both the nuclei and the cytoplasm, mainly in the cytoplasm. The cytotrophoblast, especially the nuclei was extensively positive for HMGB1 in early-onset pre-eclampsia. (2) Immunoreactivities to RAGE: positive immunostaining for HMGB1 was observed in syncytiotrophoblast, macrophages and endothelial cells in the placentas from the preeclamptic women, while a low level of immunoreactivities was observed in the placentas from healthy pregnancies; the staining was in the cytoplasm and (or) cell membrane. The trophoblast was extensively positive for RAGE in early-onset pre-eclampsia. (3) Positive rate of HMGB1 expression: the expression of HMGB1 in early-onset group (73%, 11/15) and late-onset group (64%, 14/22) was significantly higher than that in normal group (17%, 2/12; P < 0.05), but no significant difference was found in early-onset group and late-onset group (P > 0.05). (4) Positive rate of RAGE expression: the expression of RAGE in early-onset group (80%, 12/15) and late-onset group (82%, 18/22) was significantly higher than that in normal group (25%, 3/12; P < 0.05), but no significant difference was found in early-onset group and late-onset group (P > 0.05). CONCLUSIONS: The increased expression of HMGB1 and RAGE in the placenta may play an important role in the pathogenesis of pre-eclampsia. The different locations may be associated with the occurrence of different onset types of pre-eclampsia.
Asunto(s)
Proteína HMGB1/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Receptores Inmunológicos/metabolismo , Adulto , Células Endoteliales/metabolismo , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Macrófagos/metabolismo , Preeclampsia/patología , Embarazo , Receptor para Productos Finales de Glicación Avanzada , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Trofoblastos/metabolismoRESUMEN
BACKGROUND: Epidemiologic studies have yielded inconsistent findings between breastfeeding and epithelial ovarian cancer (EOC) risk. OBJECTIVE: We performed a meta-analysis to summarize available evidence of the association between breastfeeding and breastfeeding duration and EOC risk from published cohort and case-control studies. DESIGN: Relevant published studies were identified by a search of MEDLINE through December 2012. Two authors (T-TG and Q-JW) independently performed the eligibility evaluation and data abstraction. Study-specific RRs from individual studies were pooled by using a random-effects model, and heterogeneity and publication-bias analyses were conducted. RESULTS: Five prospective and 30 case-control studies were included in this analysis. The pooled RR for ever compared with never breastfeeding was 0.76 (95% CI: 0.69, 0.83), with moderate heterogeneity (Q = 69.4, P < 0.001, I(2) = 55.3%). Risk of EOC decreased by 8% for every 5-mo increase in the duration of breastfeeding (RR: 0.92; 95% CI: 0.90, 0.95). The risk reduction was similar for borderline and invasive EOC and was consistent within case-control and cohort studies. CONCLUSIONS: Results of this meta-analysis support the hypothesis that ever breastfeeding and a longer duration of breastfeeding are associated with lower risks of EOC. Additional research is warranted to focus on the association with cancer grade and histologic subtypes of EOC.